{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:54:37Z","timestamp":1769640877938,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.clinthera.2009.04.003","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T09:11:21Z","timestamp":1242292281000},"page":"816-820","source":"Crossref","is-referenced-by-count":14,"title":["An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus"],"prefix":"10.1016","volume":"31","author":[{"given":"Lindsey A.","family":"Loomba-Albrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole S.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"Styne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.04.003_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMe068142","article-title":"ATP-sensitive potassium channels\u2014neonatal diabetes mellitus and beyond","volume":"355","author":"Sperling","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.04.003_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.mop.0000170517.20025.51","article-title":"Neonatal diabetes mellitus: From understudy to center stage","volume":"17","author":"Sperling","year":"2005","journal-title":"Curr Opin Pediatr."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.04.003_bib3","first-page":"71","article-title":"The genetic basis of neonatal diabetes mellitus","volume":"4","author":"Sperling","year":"2006","journal-title":"Pediatr Endocrinol Rev."},{"key":"10.1016\/j.clinthera.2009.04.003_bib4","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","article-title":"Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy","volume":"53","author":"Sagen","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.clinthera.2009.04.003_bib5","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2","volume":"89","author":"Zung","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.clinthera.2009.04.003_bib6","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: New clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes."},{"key":"10.1016\/j.clinthera.2009.04.003_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/diacare.28.3.758","article-title":"High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation","volume":"28","author":"Codner","year":"2005","journal-title":"Diabetes Care."},{"key":"10.1016\/j.clinthera.2009.04.003_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.04.003_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","author":"Stanik","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.clinthera.2009.04.003_bib10","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2337\/dc06-2134","article-title":"Sulfonylurea treatment in young children with neonatal diabetes: Dealing with hyperglycemia, hypoglycemia, and sick days","volume":"30","author":"Codner","year":"2007","journal-title":"Diabetes Care."},{"key":"10.1016\/j.clinthera.2009.04.003_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-5448.2007.00316.x","article-title":"Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide","volume":"9","author":"Bremer","year":"2008","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.clinthera.2009.04.003_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: A United States experience","volume":"9","author":"St\u00f8y","year":"2008","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.clinthera.2009.04.003_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.1979.02130010071012","article-title":"Transient neonatal diabetes mellitus. Treatment with chlorpropamide","volume":"133","author":"Kuna","year":"1979","journal-title":"Am J Dis Child."},{"key":"10.1016\/j.clinthera.2009.04.003_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpeds.2007.12.037","article-title":"Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy","volume":"153","author":"Turkkahraman","year":"2008","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2009.04.003_bib15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium: Focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180900112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180900112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T23:27:33Z","timestamp":1545262053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180900112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S014929180900112X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.04.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}